Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
ETFs with MNKD as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|2.97%||ALPS Medical Breakthroughs ETF (SBIO)||N/A (N/A)|
|1.54%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||+67.38 (43.56%)|
|0%||BioShares Biotechnology Products Fund (BBP)||N/A (N/A)|
Company Description (as filed with the SEC)
Unless the context requires otherwise, the words "MannKind," "we," "company," "us" and "our" refer to MannKind Corporation and its subsidiaries. Unless explicitly stated otherwise, AFREZZA refers to the combination of AFREZZA inhalation powder and the AFREZZA inhaler. MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes. In October 2013, we resubmitted a new drug application, or NDA, to the United States Food and Drug Administration, or FDA, seeking approval of our lead product candidate, AFREZZA (insulin human [rDNA origin]) inhalation powder. AFREZZA is an ultra rapid-acting insulin that is intended to improve glycemic control in adults with type 1 or type 2 diabetes. Diabetes is a significant health concern. ... More ...
Where does MNKD fit in the risk graph?
|Annual EPS Est:||$-0.51|
|Quarterly EPS Est:||-0.08|